Genetic determinants of 5-lipoxygenase transcription

International Archives of Allergy and Immunology

Volumn 118, Issue 2-4, 1999, Pages 275-278

  Drazen, Jeffrey M ^a   Silverman, Eric S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Asthma; Egr 1; Gene transcription; Leukotrienes; Sp 1

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CHLORAMPHENICOL ACETYLTRANSFERASE; CORE PROTEIN; LEUKOTRIENE;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; DELETION MUTANT; GENE CONSTRUCT; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING;

EID: 0032959066     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024098     Document Type: Conference Paper

References (15)

1. Samuelsson B: Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220:568-575.
2. O'Byrne PM, Israel E. Drazen JM: Antileukotrienes in the treatment of asthma. Ann Intern Med 1997;127;472-480.
3. Busse WW: The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy 1996;26: 868-879.
4. Reiss TF, Sorkness CA, Stricker W, Botto A, Busse WW, Kundu S, Zhang J: Effects of montelukast (MK-0476), a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids. Thorax 1997;52:45-48.
5. Stene DO, Murphy RC: Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes. J Biol Chem 1988; 263:2773-2778.
6. Dennis EA, Rhee SG, Billah MM, Hannun YA: Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J 1991;5:2068-2077.
7. 2 does not alter leukotriene formation. J Biol Chem 1997;272:759-765.
8. Piechele G, Golli S, Tremoli E, Maggi A: 5-Lipoxygenase gene expression in HL60 cells during differentiation with DMSO. Pharmacol Res 1993;27:53-60.
9. Steinhilber D, Hoshiko S, Grunewald J, Radmark O, Samuelsson B: Serum factors regulate 5-lipoxygenase activity in maturating HL60 cells. Biochim Biophys Acta 1993;1178:1-8.
10. Steinhilber D, Radmark O, Samuelsson B: Transforming growth factor-beta upregulates 5-lipoxygenase activity during myeloid cell maturation. Proc Natl Acad Sci USA 1993;90: 5984-5988.
11. Stankova J, Rolapleszczynski M, Dubois CM: Granulocyte-macrophage colony-stimulating factor increases 5-lipoxygenase gene transcription and protein expression in human neutrophils. Blood 1995;85:3719-3726.
12. Hoshiko S, Radmark O, Samuelsson B: Characterization of the human 5-lipoxygenase gene promoter. Proc Natl Acad Sci USA 1990;87: 9073-9077.
13. In KH, Asano K, Beier D, Grobholz J, Finn PW, Silverman EK, Silverman ES, Collins T, Fischer AR, Keith TP, Serino K, Kim SW, Desanctis GT, Yandava C, Pillari A, Rubin P, Kemp J, Israel E, Busse W, Ledford D, Murray JJ, Segal A, Tinkleman D, Drazen JM: Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997;99:1130-1137.
14. Israel E, Rubin P, Kemp JP, Grossman J, Pierson WE, Siegel SC, Tinkleman D, Murray JJ, Busse W, Segal AT, Fish J, Kaiser HB, Ledford D, Wenzel S, Rosenthal R, Cohn J. Lanni C, Pearlman H, Karahalios P, Drazen JM: The effect of inhibition of 5-lipoxygenase by zileuton in mild to moderate asthma. Ann Intern Med 1993;119:1059-1066.
15. Silverman ES, Du J, De Sanctis GT, Radmark O, Samuelsson B, Drazen JM. Collins T: Egr-1 and Sp1 interact functionally with the 5-LO promoter and its naturally occurring mutants. Am J Respir Cell Mol Biol, in press.